David Breeze Chairman, BPH Corporate Ltd.

BPH (previously BioPharmica Limited) was formed in 2004 and is a listed company on the Australian Securities Exchange under code BPH. The company is commercialising a portfolio of Australian biomedical

technologies emerging from research by leading Universities, Medical Institutes and Hospitals across Australia. Targeting large global markets BPH provides product development and commercial direction,

whilst the institutional partner provides the majority of the infrastructure and research expertise.
biopharmica.com.au/  Video: Zurich, 2010